This company has shut down. A.D.A.M. is no longer operating — its last tracked round was a Equity Crowdfunding in 2022.
Explore the Startup GraveyardA.D.A.M. is a biotech company that specializes in on-demand 3D-bioprinting with a primary focus in bone implants.
A.D.A.M. has raised $132K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in May 2022.
A.D.A.M.'s investors include Ukrainian Startup Fund, Mount Sinai Innovation Partners, WeFund Ventures.
A.D.A.M. is headquartered in Stamford, United States.
A.D.A.M. is a biotech company that specializes in on-demand 3D-bioprinting with a primary focus in bone implants.
A.D.A.M. is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"A.D.A.M. — Funding & Investors." VCBacked, May 1, 2022, https://www.vcbacked.co/company/adam-stamford. Accessed October 21, 2026.
VCBacked. (2022). A.D.A.M. — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/adam-stamford
{{cite web |title=A.D.A.M. — Funding & Investors |url=https://www.vcbacked.co/company/adam-stamford |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated